Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Raw Materials (2020 - 2022)

Updated

Pharming's Raw Materials was $4.04 million in Q2 2022, up 11.9% from $3.61 million a year earlier.

Analysis

Pharming (PHAR) Raw Materials (2020 - 2022) Analysis & Trends

At the end of FY2021, Raw Materials at Pharming came in at $4.14 million, up 50.9% from FY2020.

  • In earlier years, Raw Materials was $2.75 million in FY2020.
  • Quarterly Raw Materials has moved between $2.75 million (Q4 2020) and $4.14 million (Q4 2021) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 4.04 Mn
Dec 31, 2021 4.14 Mn
Jun 30, 2021 3.61 Mn
Dec 31, 2020 2.75 Mn
API Access

Pharming Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=PHAR&period=max&api_key=YOUR_API_KEY